1.90USD
144.14 MUSD
1.23 BUSD
43.09 M
About Kobayashi Pharmaceutical Co., Ltd.
Sector
Headquarters
Osaka
Employees (FY)
3.53 K
Website
Founded
1886
ISIN
JP3301100008
FIGI
BBG000DRSZN2
Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, air fresheners, and sanitary products. It operates through the following segments: Domestic, International, Mail Order, and Others. The Domestic segment manufactures and sells health care products, daily necessities, skin care products, and body warmers in Japan. The International segment sells beauty and health care products overseas. The Mail Order segment offers nutritional supplements and skin care products online. The Others segment includes transportation, synthetic resin container, advertising planning and production, insurance agency, and real estate businesses. The company was founded by Chubei Kobayashi in February 1886 and is headquartered in Osaka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KBYPF is 32.49 USD — it has decreased by 16.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Kobayashi Pharmaceutical Co., Ltd. stocks are traded under the ticker KBYPF.
Kobayashi Pharmaceutical Co., Ltd. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
KBYPF stock is 19.84% volatile and has beta coefficient of 0.47. Check out the list of the most volatile stocks — is Kobayashi Pharmaceutical Co., Ltd. there?
One year price forecast for Kobayashi Pharmaceutical Co., Ltd. has a max estimate of 58.70 USD and a min estimate of 42.65 USD.
KBYPF earnings for the last quarter are 0.67 USD whereas the estimation was 0.60 USD which accounts for 12.77% surprise. Estimated earnings for the next quarter are 0.40 USD. See more details about Kobayashi Pharmaceutical Co., Ltd. earnings.
Kobayashi Pharmaceutical Co., Ltd. revenue for the last quarter amounts to 304.42 M USD despite the estimated figure of 301.45 M USD. In the next quarter revenue is expected to reach 387.93 M USD.
Yes, you can track Kobayashi Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
KBYPF net income for the last quarter is 34.29 M USD, while the quarter before that showed 51.09 M USD of net income which accounts for −32.88% change. Track more Kobayashi Pharmaceutical Co., Ltd. financial stats to get the full picture.
Today Kobayashi Pharmaceutical Co., Ltd. has the market capitalization of 2.68 B, it has decreased by 19.31% over the last week.
Kobayashi Pharmaceutical Co., Ltd. dividend yield was 1.49% in 2023, and payout ratio reached 37.66%. The year before the numbers were 1.00% and 34.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, KBYPF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kobayashi Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 3.53 K employees. See our rating of the largest employees — is Kobayashi Pharmaceutical Co., Ltd. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kobayashi Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kobayashi Pharmaceutical Co., Ltd. stock shows the strong sell signal. See more of Kobayashi Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Kobayashi Pharmaceutical Co., Ltd. future price: according to them, KBYPF price has a max estimate of 58.70 USD and a min estimate of 42.65 USD. Read a more detailed Kobayashi Pharmaceutical Co., Ltd. forecast: see what analysts think of Kobayashi Pharmaceutical Co., Ltd. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kobayashi Pharmaceutical Co., Ltd. EBITDA is 225.64 M USD, and current EBITDA margin is 18.36%. See more stats in Kobayashi Pharmaceutical Co., Ltd. financial statements.